1. Hou, Teng, Zhou, Lijie, Wang, Longwang, Zhang, Xiaoping, Chen, Zhaohui. 2018. Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway. In Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 47, 2250-2260. doi:10.1159/000491536. https://pubmed.ncbi.nlm.nih.gov/29975926/
2. Sahu, Surasri Nandan, Nunez, Stephanie, Bai, Guang, Gupta, Anandarup. 2007. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells. In American journal of physiology. Cell physiology, 292, C2288-96. doi:. https://pubmed.ncbi.nlm.nih.gov/17329398/
3. Sato, Keiko, Miura, Kentaro, Tamori, Shoma, Akimoto, Kazunori. . Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer. In Cancer genomics & proteomics, 21, 316-326. doi:10.21873/cgp.20450. https://pubmed.ncbi.nlm.nih.gov/38670590/
4. Kaulfuss, S, von Hardenberg, S, Schweyer, S, Wolf, S, Burfeind, P. 2009. Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression. In Oncogene, 28, 3971-82. doi:10.1038/onc.2009.254. https://pubmed.ncbi.nlm.nih.gov/19701244/
5. Dai, Hai-Ping, Xue, Yong-Quan, Zhou, Jian-Wei, Wang, Yong, Zhang, Jun. . LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation. In Genes, chromosomes & cancer, 48, 1027-36. doi:10.1002/gcc.20704. https://pubmed.ncbi.nlm.nih.gov/19760607/
6. Dierks, Sascha, von Hardenberg, Sandra, Schmidt, Thomas, Burfeind, Peter, Kaulfuß, Silke. . Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon. In Oncotarget, 6, 13591-606. doi:. https://pubmed.ncbi.nlm.nih.gov/26079947/
7. Carreras, Joaquim, Hamoudi, Rifat, Nakamura, Naoya. 2020. Artificial Intelligence Analysis of Gene Expression Data Predicted the Prognosis of Patients with Diffuse Large B-Cell Lymphoma. In The Tokai journal of experimental and clinical medicine, 45, 37-48. doi:. https://pubmed.ncbi.nlm.nih.gov/32219808/